Selecting the Best HIPEC Surgeons and Hospitals in India: A Guide for Patients from Iraq

Author:- Dr. Dheeraj Bojwani Date Created:- 11-08-2026

Over the years, I have found that HIPEC, hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery, is one of the procedures Iraqi families most often hear about only after being told there is nothing more that can be done for a cancer that has spread across the lining of the abdomen. In my experience of 24 years advising patients through exactly this decision, that is very often not true, but the single factor that determines whether HIPEC genuinely helps is whether the surgeon can achieve what is called complete cytoreduction, removing essentially all visible tumour before the heated chemotherapy is delivered, and this depends entirely on the specific surgeon’s skill and experience, not simply on having access to the HIPEC equipment itself.

Healing Journeys of Iraqi Patients

Iraqi Patients Share Their Experience

Why the Choice of Surgical Oncologist in India Matters as Much as the Choice of Hospital

Based on my interactions with international patients, the published data on this point is unusually consistent across every study I have reviewed: completeness of cytoreduction is the single strongest predictor of survival after HIPEC, more important than almost any other factor. The Indian HIPEC Registry, tracking 374 patients treated between 2010 and 2016 across multiple Indian centres, achieved a complete or near-complete cytoreduction score in 83 percent of cases, a genuinely strong result reflecting real, accumulated Indian surgical experience with this technically demanding procedure. Outcomes specific to tumour type illustrate why this matters: a study of peritoneal mesothelioma patients treated in North India reported one-year survival of 86.7 percent, falling to 33.3 percent at three years, while a separate Indian series of uterine sarcoma patients with peritoneal spread reported one-year survival of 78 percent, 53 percent at three years, and 35 percent at five years, figures achieved with complete cytoreduction in 94 percent of cases. International literature on colorectal peritoneal metastases treated with HIPEC reports overall survival ranging from 63 to 93 percent depending on the specific study and patient selection, again converging on the same message: the completeness of the surgery itself, not the country or hospital in the abstract, is what determines the outcome.

How Patients from Iraq Can Verify a HIPEC Hospital’s Accreditation in India

The fastest filter I recommend to every Iraqi family calling about HIPEC is verifiable accreditation, not marketing language. Joint Commission International, JCI, audits a hospital’s overall clinical safety systems against the same standard used across the United States and Europe. The National Accreditation Board for Hospitals and Healthcare Providers, NABH, is India’s own domestic equivalent, and in my experience of 24 years advising families on this exact decision, a centre holding both marks together is a meaningfully stronger signal than either alone. For HIPEC specifically, ask one further, very direct question: what is this specific surgeon’s own completeness of cytoreduction rate, and how is it measured and reported, since this single figure matters more than almost any other statistic the hospital could offer you.

HIPEC Volume and Cytoreduction-Specific Criteria That Predict Outcomes in India

Based on my interactions with dozens of peritoneal surface malignancy programmes over the years, a surgeon’s specific volume in HIPEC and cytoreductive surgery, and their own tracked completeness of cytoreduction rate, is one of the clearest predictors of a good outcome available to a family. Ask directly, in writing:

1. What is this surgeon's own completeness of cytoreduction rate for patients with my specific tumour type and disease extent, not a general HIPEC statistic?
2. How is disease extent measured before surgery, using a formal scoring system such as the peritoneal cancer index, and what is my own specific score?
3. How many HIPEC procedures has this surgeon performed in the past year, and specifically how many for my exact primary cancer type?
4. What is the centre's own postoperative complication and mortality rate for this specific procedure, since HIPEC combined with extensive cytoreductive surgery carries genuine surgical risk that should be discussed openly?

A surgeon confident in their own outcomes will answer these specifically. A surgeon who cannot state their own completeness of cytoreduction rate, or who offers HIPEC without first properly staging the extent of disease, deserves a second opinion before you commit.

Vetting a HIPEC Hospital in India: A Guide for Patients from Iraq

Questions Patients from Iraq Should Ask About the HIPEC Team in India

HIPEC and cytoreductive surgery are never genuinely the work of one surgeon alone. In my experience of 24 years watching these programmes operate, the strongest units bring together a surgical oncologist with specific fellowship training in peritoneal surface malignancy, a medical oncologist to coordinate any chemotherapy given before or after surgery, and an intensive care team experienced specifically in managing the fluid shifts and metabolic demands that follow this particular combination of extensive surgery and heated chemotherapy. A dedicated perfusionist or trained technician managing the HIPEC delivery equipment itself is a further specific role worth confirming, since the precise temperature and circulation of the heated chemotherapy solution throughout the abdominal cavity is a technical detail that directly affects treatment effectiveness. Published research has also shown that a genuine multidisciplinary team approach is associated with meaningfully higher rates of complete cytoreduction compared with cases planned without this team structure. Ask specifically who fills each of these roles for your case, and confirm that your disease extent has been formally scored and discussed by a multidisciplinary team before HIPEC is recommended.

HIPEC Technology and Perioperative Standards in India That Patients from Iraq Should Check

The specific technology and perioperative infrastructure available change what a centre can safely offer. Ask whether the hospital uses a closed or open HIPEC technique, and ask the surgeon to explain why their preferred approach suits your specific case, since each technique has recognised advantages depending on the extent and distribution of disease. Ask whether a dedicated intensive care bed is guaranteed for the days immediately following surgery, since this extended, high-acuity recovery period is a standard and necessary part of the procedure, not an optional extra, and a hospital without guaranteed ICU capacity may be forced to delay or compromise your post-operative care. Ask also whether the hospital’s pathology team has specific experience interpreting peritoneal surface malignancy specimens, since accurate assessment of the tissue removed during surgery directly informs decisions about further treatment. Ask directly which of these specific capabilities apply to your case, not simply whether the hospital owns the equipment somewhere in the building.

Red Flags Patients from Iraq Should Watch For When Choosing a HIPEC Hospital in India

Over the years, certain patterns have become reliable warning signs for me. A surgeon who cannot state their own completeness of cytoreduction rate, offering only a general HIPEC success percentage instead, has not given you information you can actually use. A hospital that recommends HIPEC without first performing formal disease staging using a peritoneal cancer index score has not properly assessed whether complete cytoreduction is realistically achievable in your specific case. And a hospital without a dedicated intensive care plan for the days following surgery is underestimating the genuine physiological demands this combined procedure places on a patient.

Factors Every Patient from Iraq Should Weigh Before Choosing HIPEC Surgery in India

A Closing Thought for Iraqi Families

HIPEC can offer genuine hope for patients with peritoneal spread of cancer who may have been told nothing more could be done, but that hope depends entirely on a surgeon capable of achieving complete cytoreduction for your specific disease extent, not simply access to the equipment itself. Based on my interactions with international patients over more than two decades, the families who ask about completeness of cytoreduction rates, formal disease staging, and multidisciplinary planning consistently make better-informed decisions than those who accept a general reassurance alone. My role, and the role of any advisor a family works with, should be to help you ask these exact questions and confirm honestly that the specific surgeon and specific hospital in front of you are the right fit for your family’s exact diagnosis. Iraq’s families deserve the same standard of scrutiny in this decision as any family anywhere else in the world.

Sources & Further Reading

• Joint Commission International (JCI) — Accredited Organizations Directory (jointcommissioninternational.org)
• National Accreditation Board for Hospitals & Healthcare Providers (NABH), India (nabh.co)
• PubMed Central — Long-Term Survival After CRS with or without HIPEC: Report from the Indian HIPEC Registry (pmc.ncbi.nlm.nih.gov)
• PubMed Central — Cytoreductive Surgery and HIPEC for Peritoneal Mesothelioma: Outcomes from a Tertiary Cancer Care Center in India (ncbi.nlm.nih.gov/pmc)
• Society of Surgical Oncology (SSO) — Peritoneal Surface Malignancy Patient Information (surgonc.org)

Frequently Asked Questions by Iraqi Patients about Selecting a HIPEC Surgeon and Hospital in India